Turning 50 often prompts men to pay closer attention to their health, particularly concerning the prostate gland. Located below the bladder and surrounding part of the urethra, the prostate produces fluid essential for sperm and semen. While typically walnut-sized in younger men, the prostate commonly enlarges with age, a natural process that may cause urinary symptoms due to its position around the urethra.
Dr. Fam Xeng Inn, a consultant urologist at Hospital Picaso in Malaysia, highlights that prostate enlargement—known medically as benign prostatic hypertrophy (BPH)—is a frequent condition among men over 50. Although BPH is non-cancerous, it can lead to symptoms such as difficulty starting urination, weak or interrupted urine flow, increased frequency, urgency, and nocturia (waking at night to urinate). Not all men with enlarged prostates require treatment, and mild symptoms may only warrant monitoring. When symptoms interfere with quality of life, medications like alpha blockers, PDE5 inhibitors, or 5-alpha reductase inhibitors can help. Surgical options, including bipolar transurethral resection of the prostate (bipolar TURP) and minimally invasive procedures such as laser therapy and water vapor treatment, are recommended for severe or complicated cases.
Prostate cancer, which also becomes more common after 50, carries greater concerns due to its potential severity. Family history is a significant risk factor, and some evidence suggests that frequent ejaculation may reduce the risk. Early-stage prostate cancer often does not cause symptoms, so relying solely on urinary issues to detect the disease can delay diagnosis.
Screening typically involves measuring prostate-specific antigen (PSA) levels through a blood test. Elevated PSA can indicate cancer but also may reflect BPH, prostatitis, or other benign issues. Further evaluation may include magnetic resonance imaging (MRI) and, if necessary, a biopsy, which is now commonly performed via a transperineal approach. This method reduces infection risks compared to the older transrectal biopsy technique.
Men at average risk are generally advised to discuss screening with their doctors starting at age 50, while those with a family history might consider earlier assessment around age 45. Prostate cancer varies widely in aggressiveness, and treatment decisions are tailored accordingly. Low-risk localized cancers may be managed with active surveillance involving regular PSA monitoring, clinical evaluations, MRI scans, and periodic biopsies. Curative treatments for more aggressive cases include robotic-assisted prostatectomy—a minimally invasive surgery—and radiotherapy.
For advanced or metastatic prostate cancer, therapies such as hormone deprivation, chemotherapy, or radioligand therapy aim to control disease progression, alleviate symptoms, and maintain patient quality of life.
Dr. Fam advises men not to delay seeking medical advice due to embarrassment or concerns about sexual side effects, emphasizing the importance of discussing potential impacts on urinary and sexual functions before treatment. He cautions against relying on unproven supplements or “prostate support” products, noting there is no definitive diet or exercise regimen that can prevent prostate disease.
Nevertheless, maintaining overall healthy habits—regular exercise, balanced nutrition, avoiding smoking, and managing weight—supports well-being as men age. Entering one’s 50s is an opportune time to become vigilant regarding urinary changes and individual risk factors and to initiate conversations with healthcare professionals about prostate health and cancer screening.